• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Women's Health Guaranteed Positions

You would be lucky if you have a job. You best believe that Abbvie has always looked out for their people when it comes to these transitions. And LoLo is not that complicated of a sell as you make it seem. There are people over here with over 20+ years of women’s health experience!! And, Orilissa will not be sold with a BC pill. That would not be good for the indication. That’s not how that will work out. If I were you, I would start looking. It is some VERY sharp reps here!

Since you are so sharp are you aware the Relugolix was studied with estradiol and a progestin. Efficacy is there, hot flashes less than orilissa, bone loss comparable to placebo. I guess when they changed the message on type of birth control to use with Orilissa at the meeting last month you did not question why. LoLo contains 2 hormones: norethindrone (a progestin) and ethinyl estradiol (an estrogen).
 




Since you are so sharp are you aware the Relugolix was studied with estradiol and a progestin. Efficacy is there, hot flashes less than orilissa, bone loss comparable to placebo. I guess when they changed the message on type of birth control to use with Orilissa at the meeting last month you did not question why. LoLo contains 2 hormones: norethindrone (a progestin) and ethinyl estradiol (an estrogen).


Whoa! Battle of the lunch caterers! You guys are flexing some serious brain power here.

Now, can either of you tell me what’s on a Reuben sandwich?
 








Since you are so sharp are you aware the Relugolix was studied with estradiol and a progestin. Efficacy is there, hot flashes less than orilissa, bone loss comparable to placebo. I guess when they changed the message on type of birth control to use with Orilissa at the meeting last month you did not question why. LoLo contains 2 hormones: norethindrone (a progestin) and ethinyl estradiol (an estrogen).

I’m sorry, who is Myovant Sciences compared to Abbvie?! Hahahahaha! Trust me, we talked about everything that we need to know at our last meeting. We’re still gonna beat you out in the field. Lol!! Get ready!!
 








I’m sorry, who is Myovant Sciences compared to Abbvie?! Hahahahaha! Trust me, we talked about everything that we need to know at our last meeting. We’re still gonna beat you out in the field. Lol!! Get ready!!


Wow, a battle royal!!! Now, who can carry more Starbucks drinks at once?!? ANNNNDD... GO!
 




I’m sorry, who is Myovant Sciences compared to Abbvie?! Hahahahaha! Trust me, we talked about everything that we need to know at our last meeting. We’re still gonna beat you out in the field. Lol!! Get ready!!

Myovant Science developed the drug. Takeda will market it. Just think Orilissa is on track to hit 64 million for 2019. Wow that is quite an accomplishment.
 












Goodbye to WH reps. It's was nice knowing you! See ya Taytulla and Liletta!!!!!

That is a sad testimony to The Forest Touch. It was such a great Division with so much promise until the Forest Management team took over. Replacing half the tenured Reps with clueless ones from PC roles right after Liletta launch was a baffling move and it just went down hill from there. They gave us CR and SB those people speak for themselves. They told us that Linzess and Viberzi would catapult WH into the stratosphere.....6 weeks before they took it back out of our bags. Those were the days. Now who knows what they’ve been up to only the dregs are left. They were like locust who devoured and departed with no thought or care. After all it’s The Forest Way
 












abbvie reps will be toast. Realignment is happening so we can carry on when we inherit Orlissa. We are multi-product specialists, they are one trick ponies that can’t get their own product going (not blaming them, it’s just what it is). We will be good and we will take over probably half way into the new year and sell their fibroid indication like we were supposed have with Esmya. Hope I didn’t hurt any feelings...
 




abbvie reps will be toast. Realignment is happening so we can carry on when we inherit Orlissa. We are multi-product specialists, they are one trick ponies that can’t get their own product going (not blaming them, it’s just2 what it is). We will be good and we will take over probably half way into the new year and sell their fibroid indication like we were supposed have with Esmya. Hope I didn’t hurt any feelings...

Good luck with that theory! Allergan has been trying to dump WH for years now we are an asset to the company.
 




I cannot believe the arrogance of some of the women health reps. One of them told me and a few others not to bother interviewing for the Ubrelvy positions because the jobs are definitely theirs. The rep was bragging that they won PC and that guaranteed them a position. This same rep was bragging last year about how easy they won because their goal was low. I talked with some others in my division and they said they heard something similar. I hope that the people who are doing the interviews dig deeper than the surface.

I am interviewing for a position as an outsider. I keep hearing that the company is putting WH reps in these positions and not to bother because the company does not want to pay the severance. What information is out there about this?
 
























Similar threads